
Ireland will push for a global agreement on corporate taxation which “accommodates” its current low rate and allows “healthy and fair tax competition”, the country’s finance minister Paschal Donohoe said on Wednesday, April 21.
The remarks by Donohoe, who chairs the eurogroup of eurozone finance ministers, indicate that Ireland expects to clash with the US over President Joe Biden’s ambition to introduce a global minimum corporate tax rate. Biden’s proposals, which emerged earlier this month, pledged to “end the race to the bottom over multinational corporate taxation.”
That left countries with low corporate tax rates, including Ireland, bracing for a struggle. Ireland charges a corporate tax rate of 12.5%, one of the lowest in Europe.
The Biden administration wants companies to be subject to a global minimum rate of 21%; the European Commission has stated it would favor an as-yet unspecified minimum.
Refundit, which was co-founded by Israeli serial entrepreneur Uri Levine, claims that Global Blue’s success is partly because it has a dominant position in the market. In its complaint, it has asked the European Commission to intervene and bring Global Blue’s alleged anti-competitive conduct to an end.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas